CVS Health (CVS) topped fourth-quarter earnings estimates, but still saw profit slide 38% from a year ago. However, the pharmacy chain, which has a new CEO, offered a 2025 outlook that envisions a return to growth. Though the earnings outlook is below what analysts had penciled in, it was strong enough to make CVS stock the No. 1 performing S&P…
